Search results for "Genetics"
Blueprint reveals clinical slant to upcoming genomics research
The 10th anniversary of the publication of the entire sequenced human genome is celebrated with another publication, this time of clinical applications for the research. Not only can diseases be treated, but better drugs and streamlined clinical trials may result.
https://immattersacp.org/archives/2011/04/genomics.htm
1 Apr 2011
ACP releases updated Ethics Manual
ACP has released the sixth edition of the Ethics Manual, published as a supplement with the Jan. 3 Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2012/01/10/10.htm
10 Jan 2012
Boxed warning for clopidogrel: reduced effects for certain patients
A boxed warning was added to the label for clopidogrel (Plavix) to warn of reduced effectiveness in patients who metabolize the drug poorly, the FDA said last week.
https://immattersacp.org/weekly/archives/2010/03/23/9.htm
23 Mar 2010
Incontinence can hide in middle age
Women may suffer debilitating quality-of-life issues from urinary incontinence yet never mention it to their primary care physicians. The condition can be successfully managed by nonsurgical and nonpharmacological means, if physicians can tactfully bring up the subject first.
https://immattersacp.org/archives/2015/02/incontinence.htm
1 Feb 2015
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
EpiPen expiration date extended, first generic approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/10/epipen-expiration-date-extended-first-generic-approved.htm
1 Oct 2018
Warnings on testosterone, new antibiotic approved
This update covers a label change on testosterone products clarifying that they are approved only for men who have low testosterone levels, as well as the approval of ceftazidime-avibactam (Avycaz) to treat complicated intra-abdominal infections.
https://immattersacp.org/archives/2015/05/fda.htm
1 May 2015
IOM links Gulf War service to several illnesses
MKSAP Quiz: worsening dysmenorrhea with pain
https://immattersacp.org/weekly/archives/2010/04/13/2.htm
13 Apr 2010
Simvastatin to carry warning about myopathy
The cholesterol-lowering medication simvastatin will be required to carry a warning about the risk of muscle injury or myopathy, the FDA announced last week.
https://immattersacp.org/weekly/archives/2011/06/14/6.htm
14 Jun 2011
Programs start early to promote health careers
Rural facilities are recruiting their next generation of doctors early##mdash;from high school. They're offering paid, entry-level jobs to immerse the youngest scholars in a health care environment with the hope they'll pursue careers in the field.
https://immattersacp.org/archives/2012/05/education.htm
1 May 2012